SCHEMBL18409259

SCHEMBL18409259

COc1ccc(CN(C(=O)C2CC(F)(F)C2)c2nc(Cl)cc3c2ncn3C)c(OC)c1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
POLB P06746 2/20 0.37
SLC6A2 P23975 2/20 0.35
SLC6A4 P31645 2/20 0.35
GAA P10253 1/20 0.35
ALDH1A1 P00352 4/20 0.34
MAPT P10636 2/20 0.34
KDM4E B2RXH2 3/20 0.34
TSHR P16473 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
KDM2B Q8NHM5 1/20 0.34
TACR3 P29371 1/20 0.34
ADORA3 P0DMS8 1/20 0.33
ADORA2A P29274 1/20 0.33
ADORA1 P30542 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HSP90AA1 P07900 1/20 0.33
HSP90AB1 P08238 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18409112 0.91 KMT2A (0.40) MEN1KMT2APOLBSLC6A2SLC6A4
SCHEMBL18409115 0.86 POLB (0.40) MEN1KMT2APOLBGAAALDH1A1
SCHEMBL1512298 0.84 POLB (0.37) MEN1KMT2APOLBGAAALDH1A1
SCHEMBL18409179 0.84 SLC6A2 (0.36) MEN1KMT2APOLBSLC6A2SLC6A4
SCHEMBL18409264 0.83 JAK2 (0.39) MEN1KMT2APOLBSLC6A2SLC6A4
SCHEMBL18409344 0.83 JAK2 (0.47) MEN1KMT2APOLBSLC6A2SLC6A4
SCHEMBL18409260 0.83 JAK2 (0.36) MEN1KMT2APOLB
SCHEMBL18409343 0.82 JAK2 (0.38) MEN1KMT2APOLB
SCHEMBL18409258 0.81 S1PR1 (0.38) MEN1KMT2APOLBGAAALDH1A1
SCHEMBL18409171 0.79 SMN1; SMN2 (0.43) ALDH1A1MAPTKDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017012647-A1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS GALAPAGOS NV (BE) 2017-01-26 WO disclosed